Skip to main content

Amazon closes $3.9 billion buy of membership-based healthcare provider One Medical

Amazon closes $3.9 billion buy of membership-based healthcare provider One Medical

/

The FTC hasn’t stepped in so far, and now Amazon’s latest acquisition is temporarily offering new subscribers a discounted rate to try its Netflix-for-primary-care service.

Share this story

Illustration of Amazon’s wordmark on an orange, black, and tan background made up of overlapping lines.
Illustration by Alex Castro / The Verge

Amazon has closed its $3.9 billion acquisition of membership-based healthcare provider One Medical, which was originally announced last summer. For the subscription (usually $199 annually but currently discounted to $144 per year), One Medical offers members an app, 24/7 access to on-demand telehealth services over video, and guaranteed same- or next-day appointments available through more than 125 offices.

The FTC, which is reportedly considering leveling an antitrust lawsuit against Amazon, has been investigating this deal as well as others (like iRobot) made by the company. FTC spokesman Douglas Farrar said to CNBC that the investigation into this acquisition is ongoing, and “The commission will continue to look at possible harms to competition created by this merger as well as possible harms to consumers that may result from Amazon’s control and use of sensitive consumer health information held by One Medical.”

While Amazon is pumping up its deal closing with the temporarily discounted rate (which comes out to about $12 per month by applying a ONEAMAZON code), there’s nothing available yet tying the healthcare service to its Amazon Prime package or anything else. Amazon Health Services senior VP Neil Lindsay said in a press release announcing the closing that “One Medical has set the bar for what a quality, convenient, and affordable primary care experience should be like. We’re inspired by their human-centered, technology-forward approach and excited to help them continue to grow and serve more patients.”